Stroke decreases in elderly, but rises in younger patients.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 414
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 2012
Results: 175
1
2
Escitalopram reduces the risk of depression in patients with HCV treated with interferon alpha.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 414
- By:
- Publication type:
- Article
3
Updated antiplatelet guideline highlights surgical bleeding risk.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 412
- By:
- Publication type:
- Article
4
Social value of statins merits actions to broaden treatment, improve adherence, study finds.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 409
- By:
- Publication type:
- Article
5
P&T community ponders economic goals of healthcare reform and pharmacy.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 433
- By:
- Publication type:
- Article
6
Clinical pharmacists' partnership with hospices drives an evolution of PBM services.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 428
- By:
- Publication type:
- Article
7
Focus on... 2012: A year of novel pharmacologic agents in review.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 420
- Publication type:
- Article
8
FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 419
- Publication type:
- Article
9
Aubagio: Teriflunomide.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 418
- Publication type:
- Article
10
Tudorza Pressair: Aclidinium bromide.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 418
- Publication type:
- Article
11
Pipeline preview.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 418
- Publication type:
- Article
12
Ivermectin lotion eliminates head lice with 1 application.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 417
- By:
- Publication type:
- Article
13
Early therapy with basal insulin does not reduce cardiovascular outcomes in dysglycemic patients.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 417
- By:
- Publication type:
- Article
14
SSRIs risky during pregnancy and affect neonatal health.
- Published in:
- Formulary, 2012, v. 47, n. 12, p. 407
- By:
- Publication type:
- Article
15
Additional safety, tolerability data for tivozanib versus sorafenib in metastatic RCC shows fewer adverse events.
- Published in:
- 2012
- Publication type:
- Journal Article
16
Correction.
- Published in:
- 2012
- Publication type:
- Journal Article
17
New healthcare payment models to shape drug coverage, costs, and expenditures.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 405
- By:
- Publication type:
- Article
18
FDA warns of serious blood disorder resulting from abuse of Opana ER.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 403
- Publication type:
- Article
19
Pharmacists must prioritize medication reconciliation.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 402
- By:
- Publication type:
- Article
20
Improve formulary adherence through effective provider engagement.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 400
- By:
- Publication type:
- Article
21
Disease-modifying therapies for multiple sclerosis: Focus on future direction.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 392
- By:
- Publication type:
- Article
22
Dimethyl fumarate: A fumaric acid ester under investigation for the treatment of relapsing-remitting multiple sclerosis.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 386
- By:
- Publication type:
- Article
23
FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 385
- Publication type:
- Article
24
First-time generic approval.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 385
- Publication type:
- Article
25
New molecular entity.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 384
- Publication type:
- Article
26
New combination.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 384
- Publication type:
- Article
27
Pipeline preview.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 384
- Publication type:
- Article
28
Wide variation exists in antibiotic prescribing for Medicare patients based on geography, season.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 383
- By:
- Publication type:
- Article
29
Depressive symptoms are associated with opioid misuse in patients treated with chronic opioids.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 382
- By:
- Publication type:
- Article
30
Bariatric surgery associated with reduction in the incidence of type 2 diabetes.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 382
- By:
- Publication type:
- Article
31
In real-world study, benefits outweigh risk for restarting warfarin after initial GI bleed.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 381
- By:
- Publication type:
- Article
32
Correction.
- Published in:
- 2012
- Publication type:
- Correction Notice
33
ICUs vary in surveillance, infection-control practices of multidrug-resistant organisms.
- Published in:
- Formulary, 2012, v. 47, n. 11, p. 379
- By:
- Publication type:
- Article
34
Formulary decision process at Mayo Clinic leads to abandoning 80-mg dose of simvastatin.
- Published in:
- 2012
- Publication type:
- Proceeding
35
Targeting the incretin system: Novel advances in the treatment of diabetes.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 330
- By:
- Publication type:
- Article
36
Meeting Coverage. Modifying antiplatelet therapy based on platelet function testing does not improve outcomes in stroke/TIA patients.
- Published in:
- 2012
- Publication type:
- Proceeding
37
An evidence-based review of treatment options for irritable bowel syndrome.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 319
- By:
- Publication type:
- Article
38
Incretin-based therapies: A focus on safety concerns and emerging uses.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 369
- By:
- Publication type:
- Article
39
Focus on... Tofacitinib: A novel oral Janus kinase inhibitor for rheumatoid arthritis.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 350
- By:
- Publication type:
- Article
40
Current standards and future treatments of rheumatoid arthritis.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 359
- By:
- Publication type:
- Article
41
FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 349
- Publication type:
- Article
42
New molecular entity.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 348
- Publication type:
- Article
43
Take charge of medication reconciliation to reduce readmission rates.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 343
- By:
- Publication type:
- Article
44
Pipeline preview.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 348
- Publication type:
- Article
45
Former finasteride users with sexual side effects at increased risk for depressive symptoms, suicidal thoughts.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 341
- By:
- Publication type:
- Article
46
Drug Watch.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 342
- Publication type:
- Article
47
Statin use may be linked to increased cataract risk.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 341
- By:
- Publication type:
- Article
48
Teduglutide: A novel recombinant analog of human glucagon-like peptide-2 for short bowel syndrome.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 314
- By:
- Publication type:
- Article
49
FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 313
- Publication type:
- Article
50
First-time generic approvals.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 313
- Publication type:
- Article